Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
about
Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.Biomarkers for depression: recent insights, current challenges and future prospects.Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seekingDouble-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.The role of the glucocorticoids in developing resilience to stress and addiction.Adeno-associated Virus-mediated, Mifepristone-regulated Transgene Expression in the Brain.The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional StimuliTargeting nuclear receptors with marine natural products.Transient Prepubertal Mifepristone Treatment Normalizes Deficits in Contextual Memory and Neuronal Activity of Adult Male Rats Exposed to Maternal Deprivation.Dexamethasone induced miR-155 up-regulation in differentiating 3T3-L1 preadipocytes does not affect adipogenesis.
P2860
Q33590375-377DA77A-3B04-4077-83DB-B603921953A4Q33704099-482EE3CD-F851-4747-955A-8E8CF8E7FBEFQ35760239-B32FA32B-79DF-409D-A9C6-8DF904B0D281Q36346636-A9E86C1E-C5BC-4913-AB14-0D0545CE6C72Q37061076-8F28864D-6D59-43F2-83CB-813B9D010DF6Q37065552-43F49488-9AF8-4333-9011-822AC71AC949Q37299365-460EB539-E110-44A2-9DDD-91959C28704DQ37621100-C26476A4-CA99-4BE4-9094-ECB45F50EA67Q47815306-1BDFA58E-1E4E-4BE3-ACEE-D0488C239BFFQ49909330-BF1E4C4C-ED84-42AC-B65C-597CC031867F
P2860
Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@ast
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@en
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@nl
type
label
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@ast
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@en
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@nl
prefLabel
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@ast
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@en
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@nl
P2860
P3181
P1476
Mifepristone (RU-486) treatmen ...... f the therapeutic implications
@en
P2093
Allan H Young
Peter Gallagher
P2860
P3181
P407
P577
2006-03-01T00:00:00Z